Wednesday, August 18, 2021 1:23:12 PM
By: Jeff Lagerquist
Wed., August 18, 2021, 12:44 p.m.·4 min read
Tilray (TLRY.TO)(TLRY) announced its first move into the American cannabis market late Tuesday via a deal to acquire a minority stake in retailer MedMen Enterprises (MMEN.CN), following U.S. federal legalization of cannabis. Analysts suggest more acquisitions will be needed for the company to hit its 2024 U.S. sales target of up to $1.5 billion per year.
Irwin Simon, chief executive officer of the Leamington, Ont.-based pot giant, has repeatedly primed expectations for a U.S.-facing deal in recent weeks involving pot, booze or consumer packaged goods.
Under the terms announced on Tuesday, Tilray and a group of unnamed strategic investors will acquire US$165.8 million worth of outstanding senior secured convertible notes previously held by the private equity firm Gotham Green Partners. Tilray will have six months to convert the debt to equity, once the U.S. legalizes cannabis, which would give the company a 21 per cent stake in MedMen.
Toronto-listed Tilray shares climbed 4.23 per cent to $17.23 at 12:03 p.m. ET on Wednesday.
The deal echoes moves by Canopy Growth (WEED.TO)(CGC) and Cronos Group (CRON.TO)(CRON), Canadian cannabis players that have struck cross-border deals with pot producers hingeing on U.S. regulatory reforms. Simon says the deal was approved by the Toronto Stock Exchange and the Nasdaq, which currently prohibit listed companies from directly investing in U.S. cannabis plant-touching assets.
MedMen was a trend-setter in U.S. cannabis retail, once lauded as the Apple Store of legal pot. The California-based company was among the first legal pot retailers to offer a premium in-store experience, with employees wearing matching red shirts and tablets for browsing cannabis products. However, MedMen became saddled with nearly $500 million in debt, and found itself embroiled in a series of controversies that ultimately led to the departure of its co-founder and CEO.
Today, the company is in the midst of a turnaround effort led by its current chief executive Tom Lynch. MedMen says it currently runs 25 retail locations with operations spanning six U.S. states, and 21 additional licences. In its latest quarter, the company reported US$32 million in sales, down 27 per cent year over year.
In a separate announcement on Tuesday, MedMen said a group of investors led by Toronto-based Serruya Private Equity bought US$100 million of the company's stock and warrants in a private placement.
"We're buying this at a really good price," Simon told analysts on a conference call Tuesday evening. "Today represents a significant step forward in our U.S. prospects."
Under the deal announced on Tuesday, Tilray will own 68 per cent of the limited partnership acquiring the bulk of MedMen's outstanding notes. The company says it will issue nine million shares of its common stock to Gotham Green Partners, if it receives approval from shareholders to increase its pool of outstanding shares at a meeting set for Thursday. Otherwise, Tilray will pay with cash.
Simon says there is "no reason" why Tilray couldn't buy MedMen outright upon U.S. federal cannabis legalization.
Scroll back up to restore default view.
Cantor Fitzgerald analyst Pablo Zuanic says MedMen would not have been his first choice among U.S. pot assets.
"MedMen does not move the needle much for Tilray, in terms of the company's vision of accumulating U.S. cannabis assets," he wrote in a note to clients.
"While MedMen is only one small step in [Tilray's] U.S. journey, with about US$120 million in sales, it lends credence to the vision outlined less than a month ago," he added, referring to Tilray's aspirations for $4 billion in sales by 2024. The company says it expects up to $1.5 billion of that figure to come from U.S. THC assets.
CIBC analyst John Zamparo says he views the deal favourably, agreeing with Simon's assertion that MedMen offers a strong brand at a competitive price. However, he notes the company has yet to turn a profit and still carries significant debt.
"We believe MedMen carries brand equity, results have improved, and asking prices from best-in-class [multi-state cannabis operators] were likely far more expensive," he wrote in a research note. "We believe the brand has real equity and should attain profitability."
Jeff Lagerquist is a senior reporter at Yahoo Finance Canada. Follow him on Twitter @jefflagerquist.
Recent TLRY News
- 10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series • GlobeNewswire Inc. • 05/03/2024 11:07:37 AM
- Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’ • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World • GlobeNewswire Inc. • 04/25/2024 08:33:50 PM
- Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S. • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Sweetwater Brewing Unveils Modern Rebrand • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Good Supply Cannabis Brand Celebrates Earth Day and Unveils Environmental Impact of “Green You Can Feel Good About” Campaign • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Tilray Brands Lights Up 420 With Music Festivals and Celebrations Across The Country • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- 10 Barrel Brewing Adds 'Juicy Drama' to Its Award-Winning HopBurst Family • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- Montauk Brewing Releases Its First Non-Alcoholic Brew: Montauk N.A. IPA • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- U.S. Futures Show Mixed Movement, Crude Oil Prices Inch Up • IH Market News • 04/09/2024 10:42:21 AM
- Tilray Brands Announces 420 Activations Across Canada and Unveils Celebratory Product Lineup • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- UPDATE – Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend • GlobeNewswire Inc. • 04/03/2024 06:02:00 PM
- Redhook Brewery Announces New “Big Juicy Ballard” IPA and Revives IPA Daze Festival at the Brewlab on 4/20 Weekend • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Sweetwater Brewing Unveils New 420 Variety Pack • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- UPDATE – Breckenridge Brewery Partners With Denver Nuggets to Launch Championship Edition Mile High City Golden Ale • GlobeNewswire Inc. • 03/28/2024 04:50:58 PM
- SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aquarium • GlobeNewswire Inc. • 03/28/2024 12:30:00 PM
- Breckenridge Brewery Announces Special Denver Nuggets Championship Edition Mile High City Golden Ale • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024 • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- 10 Barrel Brewing Unveils Newest Ready-to-Drink Canned Cocktails • GlobeNewswire Inc. • 03/26/2024 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM